Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children.

Current opinion in infectious diseases - 1 Oct 2022

Honegger Jonathan R, Gowda Charitha

Abstract excerpt

PURPOSE OF REVIEW: Direct-acting antiviral (DAA) regimens targeting hepatitis C virus (HCV) are now approved for young children. This review examines recent DAA experience in children, current treatment recommendations and challenges, and potential treatment-as-prevention strategies. RECENT FINDINGS: In 2021, the US FDA extended approval of two pan-genotypic DAA regimens, glecaprevir/pibrentasvir and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Child, Preschool
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Hepatitis C, Chronic

Share to Infant, Newborn

Share to Pregnancy

Share to Sofosbuvir

Source

Open in PubMed Open full text

Identifiers

PMID: 35852787
DOI: 10.1097/QCO.0000000000000856
PMCID: PMC9474609

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children.PMID 35852787Read ↗

Meeting the WHO hepatitis C virus elimination goal: Review of treatment in paediatrics.Semantic proximity Read ↗

Treatment of hepatitis C in children and adolescents: how far have we reached?Semantic proximity Read ↗

Hepatitis C Virus in Children: Deferring Treatment in Expectation of Direct-Acting Antiviral Agents.Semantic proximity Read ↗

Hepatitis C virus in infants and children.Semantic proximity Read ↗

Management of Hepatitis C in Children - A New Paradigm.Semantic proximity Read ↗

Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation.Semantic proximity Read ↗

ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource-limited settings.Semantic proximity Read ↗

Management strategies for hepatitis C virus infection in children.Semantic proximity Read ↗

Pharmacokinetic evaluation of sofosbuvir/velpatasvir for the treatment of Chronic Hepatitis C in pediatrics aged 3 and older.Semantic proximity Read ↗

Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective.Semantic proximity Read ↗

Management of hepatitis C virus infection in childhood.Semantic proximity Read ↗

Burden of pediatric hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.